| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, Stephanie Coronado-Montoya, Dimitri Daldegan-Bueno, Wayne Hall, Didier Jutras-Aswad, Benedikt Fische. Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. vol 238. 2022-08-06. PMID:35932748. |
cannabis use disorder (cud) affects one-in-five cannabis users, presenting a major contributor to cannabis-associated disease burden. |
2022-08-06 |
2023-08-14 |
Not clear |
| Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, Stephanie Coronado-Montoya, Dimitri Daldegan-Bueno, Wayne Hall, Didier Jutras-Aswad, Benedikt Fische. Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. vol 238. 2022-08-06. PMID:35932748. |
epidemiological data identify the frequency of cannabis use as a risk factor for cud. |
2022-08-06 |
2023-08-14 |
Not clear |
| Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, Stephanie Coronado-Montoya, Dimitri Daldegan-Bueno, Wayne Hall, Didier Jutras-Aswad, Benedikt Fische. Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. vol 238. 2022-08-06. PMID:35932748. |
this review aimed to determine quantifiable risk-thresholds of the frequency of cannabis use for developing cud. |
2022-08-06 |
2023-08-14 |
Not clear |
| Barrett Wallace Montgomery, Meaghan H Roberts, Claire E Margerison, James C Anthon. Estimating the effects of legalizing recreational cannabis on newly incident cannabis use. PloS one. vol 17. issue 7. 2022-07-21. PMID:35862417. |
liberalized state-level recreational cannabis policies in the united states (us) fostered important policy evaluations with a focus on epidemiological parameters such as proportions [e.g., active cannabis use prevalence; cannabis use disorder (cud) prevalence]. |
2022-07-21 |
2023-08-14 |
Not clear |
| Caroline Vuilleumier, Norbert Scherbaum, Udo Bonnet, Patrik Rose. Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials. Frontiers in psychiatry. vol 13. 2022-07-11. PMID:35815028. |
the prevalence of cannabis use and cannabis use disorders (cud) has significantly increased over time. |
2022-07-11 |
2023-08-14 |
Not clear |
| Larry Keen, Arlener D Turner, Lauren George, Kimberly Lawrenc. Cannabis use disorder severity and sleep quality among undergraduates attending a Historically Black University. Addictive behaviors. vol 134. 2022-07-10. PMID:35810645. |
however, no study has examined the differences in sleep quality within individuals who meet criteria for cannabis use disorder (cud). |
2022-07-10 |
2023-08-14 |
human |
| Larry Keen, Arlener D Turner, Lauren George, Kimberly Lawrenc. Cannabis use disorder severity and sleep quality among undergraduates attending a Historically Black University. Addictive behaviors. vol 134. 2022-07-10. PMID:35810645. |
future research should assess withdrawal and cannabis use frequency among individuals who meet criteria for cud to further elucidate disturbances in sleep quality among those with cud. |
2022-07-10 |
2023-08-14 |
human |
| Margaret Haney, Gillinder Bedi, Ziva D Cooper, Evan S Herrmann, Stephanie Collins Reed, Richard W Foltin, Philip J Kingsley, Lawrence J Marnett, Sachin Pate. Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. Addiction biology. vol 27. issue 4. 2022-06-27. PMID:35754107. |
the overall absence of effects on cannabis withdrawal symptoms, self-administration or circulating ecbs relative to placebo, combined with an increase in cannabis craving, suggests celecoxib does not show promise as a potential pharmacotherapy for cud. |
2022-06-27 |
2023-08-14 |
mouse |
| Théo Andriot, Patrick Ohnmacht, Patrik Vuilleumier, Gabriel Thorens, Yasser Khazaal, Nathalie Ginovart, Tomas Ro. Electrophysiological and behavioral correlates of cannabis use disorder. Cognitive, affective & behavioral neuroscience. 2022-06-13. PMID:35698004. |
this study investigated the electrophysiological and behavioral correlates of cannabis dependence by comparing patients with a cannabis use disorder (cud; n = 24) with cannabis nonuser controls (n = 24), using resting state electroencephalogram (eeg) source-imaging. |
2022-06-13 |
2023-08-14 |
Not clear |
| Maryam Sorkhou, Rachel A Rabin, Jennifer S Rabin, Stefan Kloiber, Roger S McIntyre, Tony P Georg. Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study. The American journal on addictions. 2022-06-12. PMID:35690891. |
thus, our study aimed to determine whether a 28-day period of cannabis abstinence is associated with improvements in cognition in patients with mdd and comorbid cannabis use disorder (cud). |
2022-06-12 |
2023-08-14 |
Not clear |
| Grégoire Cleirec, Esther Desmier, Cristina Lacatus, Simon Lesgourgues, Anais Braun, Claire Peloso, Chanaëlle Obadi. Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap. Frontiers in psychiatry. vol 13. 2022-06-10. PMID:35686188. |
studies suggest that cbd may be of benefit in treating cannabis use disorder (cud). |
2022-06-10 |
2023-08-14 |
Not clear |
| Courtney R Quick, Kevin P Conway, Joel Swendsen, Emma K Stapp, Lihong Cui, Kathleen R Merikanga. Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study. JAMA psychiatry. 2022-06-01. PMID:35648395. |
cannabis use disorder (cud) is increasing in the us. |
2022-06-01 |
2023-08-13 |
Not clear |
| Nathaniel A Dell, Michael G Vaughn, Sweta Prasad Srivastava, Abdulaziz Alsolami, Christopher P Salas-Wrigh. Correlates of cannabis use disorder in the United States: A comparison of logistic regression, classification trees, and random forests. Journal of psychiatric research. vol 151. 2022-05-31. PMID:35636037. |
although several recent studies have examined psychosocial and demographic correlates of cannabis use disorder (cud) in adults, few, if any, recent studies have evaluated the performance of machine learning methods relative to standard logistic regression for identifying correlates of cud. |
2022-05-31 |
2023-08-13 |
Not clear |
| Pia M Mauro, Morgan M Philbin, Emily R Greene, José E Diaz, Melanie S Askari, Silvia S Martin. Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context. Preventive medicine reports. vol 28. 2022-05-27. PMID:35620050. |
we estimated medical cannabis and daily cannabis use, and cannabis use disorder (cud) by intersecting racial, ethnic and sexual minoritized identity subgroups. |
2022-05-27 |
2023-08-13 |
Not clear |
| Pamela J Trangenstein, Katherine Gora Combs, Jennifer M Whitehill, Marina C Jenkins, David H Jernigan, Megan A Moren. Typology of Adolescents Exposed to Non-medical Cannabis Marketing and Associations with Consumption Patterns. Prevention science : the official journal of the Society for Prevention Research. 2022-05-27. PMID:35622192. |
latent class analysis (lca) identified subtypes of cannabis marketing exposure among adolescents and assessed whether the classes were associated with three cannabis use outcomes: past 28-day use, poly-cannabis use, and symptoms of cannabis use disorder (cud). |
2022-05-27 |
2023-08-13 |
Not clear |
| Rajapaksha Mudalige Dhanushka S Rajapaksha, Francesca Filbey, Swati Biswas, Pankaj Choudhar. A Bayesian learning model to predict the risk for cannabis use disorder. Drug and alcohol dependence. vol 236. 2022-05-19. PMID:35588608. |
the prevalence of cannabis use disorder (cud) has been increasing recently and is expected to increase further due to the rising trend of cannabis legalization. |
2022-05-19 |
2023-08-13 |
Not clear |
| Rajapaksha Mudalige Dhanushka S Rajapaksha, Francesca Filbey, Swati Biswas, Pankaj Choudhar. A Bayesian learning model to predict the risk for cannabis use disorder. Drug and alcohol dependence. vol 236. 2022-05-19. PMID:35588608. |
to help stem this public health concern, a model is needed that predicts for an adolescent or young adult cannabis user their personalized risk of developing cud in adulthood. |
2022-05-19 |
2023-08-13 |
Not clear |
| Howard Padwa, David Huang, Larissa Mooney, Christine E Grella, Darren Urada, Douglas S Bell, Brittany Bass, Anne E Boustea. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state. Substance abuse treatment, prevention, and policy. vol 17. issue 1. 2022-05-08. PMID:35527269. |
this paper analyzes the relationship between documented cannabis use disorders (cud), cannabis use (cu) and other health diagnoses among primary care patients during a time when medical use of marijuana was permitted by state law in california, united states of america. |
2022-05-08 |
2023-08-13 |
Not clear |
| Dafna Sara Rubin-Kahana, Ahmed Nabeel Hassan, Marcos Sanches, Bernard Le Fol. Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample. Frontiers in psychiatry. vol 13. 2022-04-18. PMID:35432009. |
with the increasing number of cannabis users and more jurisdictions allowing medical cannabis, more evidence-based knowledge about the prevalence of cannabis use disorder (cud) among medical users is greatly needed. |
2022-04-18 |
2023-08-13 |
Not clear |
| Skyler Sklenarik, Marc N Potenza, Robert S Astu. Avoidance tendencies toward cannabis stimuli in a college sample. Journal of addictive diseases. 2022-03-31. PMID:35356853. |
individuals with problematic cannabis use who met criteria for a possible cannabis use disorder (cud) based on cudit-r criteria were significantly slower to avoid but not to approach cannabis stimuli compared to individuals with nonuse and non-problematic use. |
2022-03-31 |
2023-08-13 |
human |